TABLE 1.

Treatment matrix and procedural details

		Number of ablations								Ratio of numbers of ablations (branch/main)
Group	Animal ID	Left			Right					Left	Right	Mean ± SD
		Branch	Main	Total	Branch	Main	Total	Total/animal	Mean ± SD
Group SPY	SP1	14	5	19	11	9	20	39	33.2 ± 3.3	2.8	1.2	1.4 ± 0.7
	SP2	7	6	13	8	10	18	31		1.2	0.8
	SP3	8	4	12	10	9	19	31		2.0	1.1
	SP4	10	5	15	8	9	17	32		2.0	0.9
	SP5	8	9	17	6	10	16	33		0.9	0.6
Group IBB	IB1	7	6	13	7	10	17	30	26.2 ± 3.3	1.2	0.7	0.9 ± 0.5
	IB2	8	6	14	5	8	13	27		1.3	0.6
	IB3	5	4	9	6	6	12	21		1.3	1.0
	IB4	2	10	12	4	11	15	27		0.2	0.4
	IB5	8	5	13	4	9	13	26		1.6	0.4
Sham group	Sham1
	Sham2	No ablations performed
	Sham3

Top: five animals were treated with the Symplicity Spyral system (group SPY). All animals of this group received 33.2 ± 3.3 ablations in main and branch arteries. The ratio of number of ablations (branch/main) was 1.4 ± 0.7. Middle: five animals were treated with the IberisBloom system (group IBB). All animals of this group received 26.2 ± 3.3 ablations in main and branch arteries. The ratio of number of ablations (branch/main) was 0.9 ± 0.5. Bottom: three animals received sham procedure (Sham Group) with zero ablations. IBB, IberisBloom; SPY, Symplicity Spyral.